-
1
-
-
84455194972
-
FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury
-
U.S. Food and Drug Administration, Department of Health and Human Services, March 19, 2010. Available at Cited July 12, 2011.
-
FDA Drug Safety Communication: Ongoing safety review of high-dose Zocor (simvastatin) and increased risk of muscle injury. U.S. Food and Drug Administration, Department of Health and Human Services, March 19, 2010. Available at http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm204882.htm. Cited July 12, 2011. http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm204882.htm.
-
-
-
-
2
-
-
80054699298
-
FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury
-
U.S. Food and Drug Administration, Department of Health and Human Services, June 8, 2011. Available at: Cited July 12, 2011.
-
FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. U.S. Food and Drug Administration, Department of Health and Human Services, June 8, 2011. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm. Cited July 12, 2011. http://www.fda.gov/Drugs/DrugSafety/ucm256581.htm.
-
-
-
-
4
-
-
84856573109
-
-
Top 200 generic drugs by total prescriptions. SDI's Vector One®: National, June 2011. Available at:, Cited July 12, 2011.
-
2010 Top 200 generic drugs by total prescriptions. SDI's Vector One®: National, June 2011. Available at: http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/252011/727243/article.pdf. Cited July 12, 2011. http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/252011/727243/article.pdf.
-
(2010)
-
-
-
5
-
-
84856579754
-
-
Top 200 generic drugs by retail dollars. SDI's Vector One®: National, June 2011. Available at:
-
2010 Top 200 generic drugs by retail dollars. SDI's Vector One®: National, June 2011. Available at: http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/252011/727239/article.pdf. http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/252011/727239/article.pdf.
-
(2010)
-
-
-
6
-
-
84856568278
-
-
Package Inserts obtained from Drugs@FDA, July 11, 2011. Available at: Cited July 12, 2011.
-
Package Inserts obtained from Drugs@FDA, July 11, 2011. Available at: http://dailymed.nlm.nih.gov/dailymed/about.cfm. Cited July 12, 2011. http://dailymed.nlm.nih.gov/dailymed/about.cfm.
-
-
-
-
8
-
-
33645889332
-
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force
-
McKenney J.M., Davison M.H., Jacobson T.A., et al. Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol 2006, 97(suppl):89C-94C.
-
(2006)
Am J Cardiol
, vol.97
, Issue.SUPPL.
-
-
McKenney, J.M.1
Davison, M.H.2
Jacobson, T.A.3
|